SL BIO Ltd. (SLBT) commenced trading on the Nasdaq Global Market beginning on June 15, 2026, following a business combination with Horizon Space Acquisition II Corp. (Nasdaq: HSPT), a special purpose acquisition company.
The completion of this business combination carries an implied equity valuation of SL Bio of approximately $5.568 billion.
The Taiwan-headquartered SL BIO is a biomedical company specializing in developing innovative cellular and gene therapies.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.